George Burslem

George M. Burslem obtained his undergraduate degree in Chemistry from the University of Bristol, spending a year in the Chemical Biology group at Pfizer. He carried out his master’s research with Professor Tom Simpson FRS at Bristol before moving to the University of Leeds for his doctoral studies under the supervision of Professors Andrew Wilson and Adam Nelson focused on inhibiting protein-protein interactions. He was awarded his PhD in 2015 and moved to Yale University to preform postdoctoral research in the group of Professor Craig Cerews, supported by a Leukemia and Lymphoma Society Career Development award. In January 2020, George started his independent career at the University of Pennsylvania as an Assistant Professor in the Departments od Biochemistry and Biophysics, Cancer Biology an d the Penn Epigenetics Institute. The Burslem lab uses chemical biology, biochemistry, proteomics and cell biology to study and modulate the roles of post-translational modifications in disease, He was recently awarded an AACR NextGen Star Award, a BBA Rising Star in Biochemistry and Biophysics award and he NIH Director’s Transformative Research Award.